M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Return to Archives
New Search
Lorus Therapeutics Inc announces USD600,000 from Escrow Account
Lorus Therapeutics Inc (TSX: LOR, AMEX: LRP), a biopharmaceutical company specialising in the research and development of pharmaceutical products and technologies for the management of cancer, declared on 16 July the receipt of USD600,000, originally held in escrow in connection with the company's...
If you want to view the full text of this story, you must first purchase archive retrieval credits.